Exelixis
EXEL
#1855
Rank
HK$86.98 B
Marketcap
HK$323.13
Share price
-2.18%
Change (1 day)
25.05%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company